Table 1.
Variable | “One-Day” | “Two-Day” | p-value |
---|---|---|---|
n = 550 | n = 67 | ||
Age (years) | 58.3 (12.8) | 57.9 (13.2) | 0.81 |
BMI (kg/m2) | 26.6 (6.2) | 26.0 (6.4) | 0.42 |
Neoadjuvant Therapy | 0.83 | ||
None | 454 (89.1%) | 55 (10.8%) | |
Chemotherapy | 80 (87.9%) | 11 (12.1%) | |
Hormonal | 16 (94.1%) | 1 (5.9%) | |
Surgeon | <0.01* | ||
#1 | 249 (81.6%) | 56 (18.4%) | |
#2 | 301 (96.5%) | 11 (3.5%) | |
Surgery Performed | <0.01* | ||
Mastectomy | 163 (82.3%) | 35 (17.7%) | |
Lumpectomy | 378 (92.9%) | 29 (7.1%) | |
SLN biopsy only | 9 (75.0%) | 3 (25.0%) | |
Nuclear Radiologist | 0.66 | ||
#1 | 264 (89.8%) | 30 (10.2%) | |
#2 | 268 (88.7%) | 34 (11.3%) | |
#3 | 18 (85.7%) | 3 (14.3%) | |
Use of Frozen Section | 202 (36.7%) | 36 (53.7%) | 0.01* |
≥ 1 Positive-Node | 85 (15.4%) | 10 (14.9%) | 1.00 |
≥ 1 “Hot” node | 544 (98.9%) | 65 (97.0%) | 0.21 |
≥ 1 “Blue” node | 489 (88.9%) | 61 (91.0%) | 0.75 |
Variables represent frequencies n (percentages) or means (standard deviation)
Legend: SLN: sentinel lymph node
statistically significant